[Hypertrophic cardiomyopathies--present knowledge].
Hypertrophic cardiomyopathies are observed under 3 anatomic forms: septal, concentric, apical. Their pathogenesis is still unknown. Theorie involving catecholamine appears the most acceptable. Among the diagnostic signs, septum cellular disorganization is the precise anatomic criteria. Obstructive cardiomyopathy is no longer an isolated entity, but a form of transition between the three anatomic forms. Pronostic is dominated by sudden death; amiodarone is the best preventive treatment.
Touze
J E
JE
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides
Les cardiomyopathies hypertrophiques--données actuelles.